ASSIST: Treatment for Childhood Apraxia of Speech
ASSIST
ASSIST: Child Apraxia Speech Treatment
1 other identifier
interventional
420
1 country
1
Brief Summary
Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In three small randomized group design studies, children (N=20 per study) receive 16 hours of individual ASSIST. The three studies systematically investigate treatment intensity (2 vs. 4 weeks) and two critical aspects of target selection: complexity (simple vs. complex target) and lexicality (words vs. nonwords). Each study also systematically examines the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Apr 2019
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2019
CompletedFirst Posted
Study publicly available on registry
April 4, 2019
CompletedStudy Start
First participant enrolled
April 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedMarch 4, 2025
February 1, 2025
5.4 years
March 29, 2019
March 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Speech Accuracy of Treated Items
Perceptual accuracy of treated items, judged by blinded listeners. Will be used to address Aim 1 (initial efficacy of ASSIST) and Aims 2 (optimal parameters of ASSIST).
1 week post treatment
Secondary Outcomes (4)
Speech Accuracy of Untreated Generalization Items
1 week post treatment
ICS Average Score
1 week post treatment
FOCUS-34 Total Score
1 week post treatment
TOCS+ Intelligibility (percentage words correctly understood)
1 week post treatment
Study Arms (4)
ASSIST
EXPERIMENTALStudy 1 and 2
Delayed Control
NO INTERVENTIONStudy 1 and 2
Massed ASSIST
EXPERIMENTALStudy 3
Distributed ASSIST
EXPERIMENTALStudy 3
Interventions
Integral stimulation based treatment ("watch me, listen to me, say what I say") for CAS that is based on principles of motor learning and neuroplasticity and includes a systematic approach to adaptive practice. Treatment includes a focus on prosody, use of visual, tactile, auditory cues, slowing speech rate, and large amounts of practice.
Eligibility Criteria
You may qualify if:
- Age between 4;0 and 9;11 (years;months) at enrollment, based on parent report.
- From homes where the primary language spoken is English, based on parent report.
- Verbal output (50+ words) and communicative intent, as determined by the clinician and parent report.
- Speech sound disorder, as determined by a score \<16th percentile on the Diagnostic Evaluation of Articulation and Phonology (DEAP) Articulation Assessment (Dodd et al., 2006) and/or the Goldman-Fristoe Test of Articulation (Goldman \& Fristoe, 2015).
- CAS as a primary speech diagnosis, based on the following criteria:
- An average rating \> 1 across three expert speech-language pathologists (SLPs), who will independently rate presence of CAS in children live or from video recordings of the assessment using a 3-point scale (0 = no CAS, 1 = possible CAS, 2 = CAS). These judgments will be based on perceptual speech features of CAS (inconsistent vowel and consonant errors, difficulties achieving and transitioning into articulatory configurations, abnormal prosody).
- An Apraxia Score of 1 or 2 on a Maximum Performance protocol in which they sustain vowels and fricatives as long as possible and repeat syllables as fast as possible (Rvachew et al., 2005; Thoonen et al., 1999).
- Normal hearing based on parent report or passing a standard pure-tone audiometry hearing screening at 500, 1000, 2000, and 4000 Hz (ASHA, 1997).
- Typical nonverbal cognition as determined by a T-score within 1.5 standard deviation (SD) of the mean on nonverbal subtests of the Reynolds Intellectual Assessment Scales (Reynolds \& Kamphaus, 2003).
You may not qualify if:
- Diagnosis of disorder that significantly affects communication and/or social interactions (e.g., autism), as per referral diagnosis.
- Uncorrected vision impairments that may interfere with ability to process visual cues used in treatment, as per parent report.
- Significant impairments of oral structure (e.g., cleft palate) as judged by the SLP based on an oral mechanism exam (Robbins \& Klee, 1987).
- A primary diagnosis of dysarthria, as judged by the SLP.
- Unrelated health concerns that prevent children from participating, per parent report.
- Inability to meet toileting needs independently or separate from parent for a full day (as needed for camp), based on parent report.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Temple University
Philadelphia, Pennsylvania, 19122, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edwin Maas, Ph.D.
Temple University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Data Collector also masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2019
First Posted
April 4, 2019
Study Start
April 18, 2019
Primary Completion
August 31, 2024
Study Completion
March 31, 2025
Last Updated
March 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Within 1 year after the primary publication based on those data has been accepted for publication.
- Access Criteria
- Data access will only be provided upon submitting a completed and signed data sharing agreement to the PI.
Data spreadsheets containing finalized outcome measures for each child (e.g., speech accuracy data and intelligibility data) will be made available upon request to the PI to interested researchers, speech-language pathologists, and members of the general public. These data will be de-identified.